NGNE vs RUN · $286.5M cap vs P/E 6.0, rev $1.59B
Neurogene Inc (NGNE) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Neurogene Inc (NGNE) is a biotechnology company listed on US.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported NGNE revenue for 2025-09-30 was $0. Net income was -$21.0M. NGNE currently screens at market cap $286.5M.
Latest reported RUN revenue for 2026-06-30 was $1.59B. Net income was $282.8M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
NGNE currently screens at market cap $286.5M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the NGNE and RUN stock pages for the full models.
Not investment advice.